{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:42:11Z","timestamp":1791384131296,"version":"4.3.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10075-y","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:03:41Z","timestamp":1729519421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003\u20132022"],"prefix":"10.1186","volume":"24","author":[{"given":"Yasiini","family":"Nuwamanya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculate","family":"Ampeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baganizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritah","family":"Atugonza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Nsubuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benon","family":"Kwesiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Migisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Bulage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kadobera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Riolexus","family":"Ario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Kisakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"10075_CR1","unstructured":"mondiale de la Sant\u00e9 O, Organization WH. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper\u2013February 2019 Vaccins antipneumococciques conjugu\u00e9s chez les nourrissons et les enfants de moins de 5 ans: note de synth\u00e8se de l\u2019OMS\u2013f\u00e9vrier 2019. Weekly Epidemiological Record\u2009=\u2009Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire. 2019;94(08):85\u2013103."},{"key":"10075_CR2","unstructured":"WHO, Pneumococcal Disease. 2023. https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/vaccine-standardization\/pneumococcal-disease"},{"key":"10075_CR3","unstructured":"WHO. Pneumococcal meningitis-Togo 2023 [updated 11-4-2023]. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON455"},{"issue":"2","key":"10075_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/cid\/cix310","volume":"65","author":"G Oligbu","year":"2017","unstructured":"Oligbu G, Collins S, Sheppard CL, Fry NK, Slack M, Borrow R, et al. Childhood deaths attributable to invasive pneumococcal disease in England and Wales, 2006\u20132014. Clin Infect Dis. 2017;65(2):308\u201314.","journal-title":"Clin Infect Dis"},{"issue":"Supplement2","key":"10075_CR5","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/cid\/ciz472","volume":"69","author":"JM Mwenda","year":"2019","unstructured":"Mwenda JM, Soda E, Weldegebriel G, Katsande R, Biey JN-M, Traore T, et al. Pediatric bacterial meningitis surveillance in the World Health Organization African region using the invasive bacterial vaccine-preventable disease surveillance network, 2011\u20132016. Clin Infect Dis. 2019;69(Supplement2):S49\u201357.","journal-title":"Clin Infect Dis"},{"issue":"10186","key":"10075_CR6","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/S0140-6736(18)33005-8","volume":"393","author":"LL Hammitt","year":"2019","unstructured":"Hammitt LL, Etyang AO, Morpeth SC, Ojal J, Mutuku A, Mturi N, et al. Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study. Lancet. 2019;393(10186):2146\u201354.","journal-title":"Lancet"},{"issue":"6","key":"10075_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","volume":"16","author":"GA Mackenzie","year":"2016","unstructured":"Mackenzie GA, Hill PC, Jeffries DJ, Hossain I, Uchendu U, Ameh D, et al. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in the Gambia: a population-based surveillance study. Lancet Infect Dis. 2016;16(6):703\u201311.","journal-title":"Lancet Infect Dis"},{"issue":"Supplement2","key":"10075_CR8","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1086\/596495","volume":"48","author":"A Kisakye","year":"2009","unstructured":"Kisakye A, Makumbi I, Nansera D, Lewis R, Braka F, Wobudeya E, et al. Surveillance for Streptococcus pneumoniae meningitis in children aged\u2009<\u20095 years: implications for immunization in Uganda. Clin Infect Dis. 2009;48(Supplement2):S153\u201361.","journal-title":"Clin Infect Dis"},{"key":"10075_CR9","unstructured":"UNEPI. Immunization guidelines 2022. https:\/\/www.health.go.ug\/wp-content\/uploads\/2019\/11\/UNEPI-Immunization-guidelines.pdf"},{"key":"10075_CR10","unstructured":"Health Mo. 2023 [updated 15-6-2023]. https:\/\/hmis.health.go.ug\/dhis-web-data-visualizer\/index.html#\/"},{"key":"10075_CR11","unstructured":"Immunization WHODo. Immunization in practice: a practical guide for health staff. World Health Organization; 2015."},{"issue":"12","key":"10075_CR12","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S1473-3099(22)00438-8","volume":"22","author":"TD Swarthout","year":"2022","unstructured":"Swarthout TD, Henrion MY, Thindwa D, Meiring JE, Mbewe M, Kalizang\u2019Oma A, et al. Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3\u2009+\u20090 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study. Lancet Infect Dis. 2022;22(12):1737\u201347.","journal-title":"Lancet Infect Dis"},{"key":"10075_CR13","unstructured":"Organization WH. Overview of VPD surveillance principles 2018 [cited 2023 August 2023]. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/vpd_surveillance\/vpd-surveillance-standards-publication\/who-surveillancevaccinepreventable-01-overview-r2.pdf?sfvrsn=932d9e08_8&download=true"},{"key":"10075_CR14","unstructured":"Health UMo. Coverage for key antigens 2023. https:\/\/hmis.health.go.ug\/dhis-web-dashboard\/#\/"},{"key":"10075_CR15","unstructured":"Statistics UBo, Population, Censuses. 2023. https:\/\/www.ubos.org\/explore-statistics\/20\/"},{"issue":"Supplement2","key":"10075_CR16","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1093\/cid\/ciz474","volume":"69","author":"BN Tagbo","year":"2019","unstructured":"Tagbo BN, Bancroft RE, Fajolu I, Abdulkadir MB, Bashir MF, Okunola OP, et al. Pediatric bacterial meningitis surveillance in Nigeria from 2010 to 2016, prior to and during the phased introduction of the 10-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2019;69(Supplement2):S81\u20138.","journal-title":"Clin Infect Dis"},{"key":"10075_CR17","unstructured":"UNICEF Wa. Uganda: WHO and UNICEF estimates of immunization coverage: 2022 revision 2023. https:\/\/www.google.com\/search?q=Uganda%3A+WHO+and+UNICEF+estimates+of+immunization+coverage%3A+2022+revision&oq=Uganda%3A+WHO+and+UNICEF+estimates+of+immunization+coverage%3A+2022+revision&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIGCAEQRRg6MgYIAhBFGDzSAQgxMzk5ajBqN6gCALACAA&sourceid=chrome&ie=UTF-8"},{"key":"10075_CR18","unstructured":"Organization WH. Immunization in practice: a practical guide for health staff, 2015 update 2015. https:\/\/iris.who.int\/handle\/10665\/193412"},{"issue":"5","key":"10075_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/INF.0000000000000279","volume":"33","author":"AM Loughlin","year":"2014","unstructured":"Loughlin AM, Hsu K, Silverio AL, Marchant CD, Pelton SI. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts\u2019 children. Pediatr Infect Dis J. 2014;33(5):504\u201310.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10075_CR20","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1080\/21645515.2020.1787065","volume":"16","author":"I Ali","year":"2020","unstructured":"Ali I. Impact of COVID-19 on vaccination programs: adverse or positive? Hum Vaccines Immunotherapeutics. 2020;16(11):2594\u2013600.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"3","key":"10075_CR21","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/ijerph18030988","volume":"18","author":"ZS Lassi","year":"2021","unstructured":"Lassi ZS, Naseem R, Salam RA, Siddiqui F, Das JK. The impact of the COVID-19 pandemic on immunization campaigns and programs: a systematic review. Int J Environ Res Public Health. 2021;18(3):988.","journal-title":"Int J Environ Res Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10075-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10075-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10075-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T02:01:54Z","timestamp":1729562514000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10075-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10075"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10075-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We used retrospective surveillance data and did not directly engage any participant for this study. The Ministry of Health Uganda provided administrative clearance to conduct this study as part of the routine national public health surveillance data analysis for action. The US Centers for Disease Control and Prevention (CDC) provided the non-research determination (NRD) for non-human subjects. In agreement with the International Guidelines for Ethical Review of Epidemiological Studies by the Council for International Organizations of Medical Sciences (1991) and the Office of the Associate Director for Science, US CDC\/Uganda, it was determined that this activity was not human subject research and that its primary intent was to improve public health practice or disease control. This activity was reviewed by the US CDC and was conducted consistent with applicable federal law and CDC policy. \u00a7\u00a7See, e.g., 45\u00a0C.F.R. part 46, 21\u00a0C.F.R. part 56; 42 U.S.C. \u00a7\u00a0241(d); 5 U.S.C. \u00a7\u00a0552a; 44 U.S.C. \u00a7\u00a03501 et seq.\u00a0The protocol was approved by the US CDC human subjects review board (The National Institute for Occupational Safety and Health Institutional Review Board) and the Uganda Ministry of Health and the study performed in accordance with the Declaration of Helsinki. All individualized surveillance records were anonymized and kept confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1187"}}